Combination of Diuretics in States of Resistant Nephrotic Edema: a Case Presentation
- 15 September 2024
- journal article
- Published by TARUS Media in Mædica
- Vol. 19 (3) , 641-647
Abstract
While there remains no universally accepted definition for resistant edema, it is generally acknowledged as edema that fails to respond to maximally administered doses of diuretics. Nephrotic edema is characterized by high levels of proteinuria, notably urinary concentrations of serine proteases, which possess the ability to activate the epithelial sodium channel (ENaC), resulting in persistent fluid retention. Loop diuretics are typically preferred as first-line therapy for hypervolemia. However, the sustained activation of ENaC channels may lead to resistance to treatment. Consequently, the blockade of ENaC represents a potential therapeutic approach. We report the case of a 36-year-old man presenting with nephrotic edema managed with a combination of furosemide and human albumin. Despite an initially favorable response, the patient subsequently developed oliguria and progressive weight gain. On the third day, a regimen comprising amiloride (5 mg/day) and hydrochlorothiazide (50 mg/day) was initiated, resulting in complete resolution of edema after 11 days. No hyperkalemia was observed, with only a slight elevation in serum creatinine levels. Although clinical trials are limited, mounting evidence from human and animal studies supports the concept of nephrotic syndrome as an overfill phenomenon and underscores the potential benefits of ENaC blockers in the management of nephrotic edema.Keywords
This publication has 18 references indexed in Scilit:
- Amiloride: the “new” renal tonic?American Journal of Physiology-Renal Physiology, 2015
- Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urineAmerican Journal of Physiology-Renal Physiology, 2015
- Nonimmunologic targets of immunosuppressive agents in podocytesKidney Research and Clinical Practice, 2015
- Urinary serine proteases and activation of ENaC in kidney—implications for physiological renal salt handling and hypertensive disorders with albuminuriaPflügers Archiv - European Journal of Physiology, 2014
- Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuriaNephrology Dialysis Transplantation, 2011
- Update in Diuretic Therapy: Clinical PharmacologySeminars in Nephrology, 2011
- Plasmin in Nephrotic Urine Activates the Epithelial Sodium ChannelJournal of the American Society of Nephrology, 2009
- Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy.2001
- Potassium‐sparing effect of amiloride in a diuretic factorial study in manClinical and Experimental Pharmacology and Physiology, 1975
- Evaluation of MK-870: a new potassium-sparing diuretic.BMJ, 1967